Concepedia

Paul R. Kunk

PR

Statistics

Publications

10

Citations

319

H-Index

10

Active since

2016

Affiliations

University of Virginia(Current)

University of Virginia Health System

Dana-Farber Cancer Institute

Paul R. Kunk is an author at University of Virginia specializing in medicine, tumor immunity, and molecular oncology.

ORCID

Top concepts

Publications per year

2016–2022

10

Publications

10

Sarcoidosis in the setting of combination ipilimumab and nivolumab immunotherapy: a case report & review of the literature

Joshua E. Reuss, Paul R. Kunk, Anne M. Stowman et al. · Journal for ImmunoTherapy of Cancer · 2016 · 95 citations · Full text

Risk of Major Bleeding with Ibrutinib

J.N. Mock, Paul R. Kunk, Surabhi Palkimas et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 62 citations

, , +7

Direct oral anticoagulants in hypercoagulable states

Paul R. Kunk, Jacqueline T. Brown, Melissa McShane et al. · Journal of Thrombosis and Thrombolysis · 2016 · 35 citations

, , +11

Mismatch Repair Protein Deficiency/Microsatellite Instability Is Rare in Cholangiocarcinomas and Associated With Distinctive Morphologies

Jennifer Y. Ju, Megan E. Dibbern, Mani S. Mahadevan et al. · American Journal of Clinical Pathology · 2019 · 30 citations · Full text

Major Bleeding with Ibrutinib: More Than Expected

Paul R. Kunk, Joesph Mock, Michael Devitt et al. · Blood · 2016 · 21 citations

1–5 of 10